Pluripotent stem cells are a class of pluripotent cells with the ability to self-renew indefinitely in vitro and differentiate into various cell types in the body. They are important tools for studying gene function, building disease models and advancing the field of regenerative medicine.
The pluripotency of stem cells is regulated and maintained by transcriptional networks that include a series of pluripotent transcription factors. These pluripotent genes stimulate or inhibit the expression of downstream genes, inducing the occurrence of some signaling pathways and regulating the pluripotency of stem cells.
Stem cells retain the potential for self-renewal and multidirectional differentiation in the action of signaling pathways regulating the pluripotency of stem cells. Having a better understanding of the mechanism of these pathways could help scientists study gene function ＆ disease pathogenesis and promote the development of regenerative medicine.
Human pluripotent stem cells (hPSCs) are originally established on the feeder layer, murine embryo fibroblast (MEF) irradiated or treated with mitomycin. The feeder layer not only provides nutrition for cell growth but also secrets cytokines (Activin A, IGF-2) that synergize with bFGF (basic fibroblast growth factor) in the culture solution to maintain the pluripotency of human stem cells.
Low concentrations of bFGF can maintain the pluripotency of hPSC in the presence of feeder cells. Because the insulin-like growth factor (IGF) induced by bFGF activates the PI3K-AKT signaling pathway, which inhibits the expression of GSK3, inhibiting the degradation of β-Catenin and maintaining the pluripotency of hPSCs.
Besides, Activin/Nodal/TGF-β respectively binds to their receptors on the cell membrane in the presence of bFGF, activating intracellular cytoplasmic SMAD2/SMAD3. Active SMAD2/3 and SMAD4 form heterodimers into the nucleus, regulating the expression of related genes that maintain the pluripotency of hPSCs. SMAD2/3 can be directly conjugated to the proximal promoter region of Nanog to upregulate the expression of this gene. When the expression of Nanog is increased, the expression of SMAD2/3 is inhibited by negative feedback regulation, and Activin/Nodal/TGF-β signaling pathway in hPSC is controlled to ensure that hPSCs cannot be induced to differentiate into mesendoderm.
BMP4 (bone morphognic protein 4) binds to BMPR, phosphorylating cellular SMAD1, SMAD5, and SMAD8 rather than SMAD2/3. Phosphorylated SMAD1/5/8 further binds to SMAD4 and enters into the nucleus to modulate transcription. When BMP4 in the culture solution is not enough to maintain hPSC self-renewing, the BMP4-SMAD1/5/8 signaling upregulates with the differentiation of hPSCs.
|ACVR1||ACVR1 Antibody||ACVR1 Protein||ACVR1 cDNA||ACVR1 ELISA Kit|
|ACVR1B||ACVR1B Antibody||ACVR1B Protein||ACVR1B cDNA||ACVR1B ELISA Kit|
|ACVR1C||ACVR1C Antibody||ACVR1C Protein||ACVR1C cDNA||ACVR1C ELISA Kit|
|ACVR2A||ACVR2A Antibody||ACVR2A Protein||ACVR2A cDNA||ACVR2A ELISA Kit|
|ACVR2B||ACVR2B Antibody||ACVR2B Protein||ACVR2B cDNA||ACVR2B ELISA Kit|
|AKT1||AKT1 Antibody||AKT1 Protein||AKT1 cDNA||AKT1 ELISA Kit|
|AKT2||AKT2 Antibody||AKT2 Protein||AKT2 cDNA||AKT2 ELISA Kit|
|AKT3||AKT3 Antibody||AKT3 Protein||AKT3 cDNA||AKT3 ELISA Kit|
|APC||APC Antibody||APC Protein||APC cDNA||APC ELISA Kit|
|APC2||APC2 Antibody||APC2 Protein||APC2 cDNA||APC2 ELISA Kit|
|AXIN1||AXIN1 Antibody||AXIN1 Protein||AXIN1 cDNA||AXIN1 ELISA Kit|
|AXIN2||AXIN2 Antibody||AXIN2 Protein||AXIN2 cDNA||AXIN2 ELISA Kit|
|BMP4||BMP4 Antibody||BMP4 Protein||BMP4 cDNA||BMP4 ELISA Kit|
|BMPR1A||BMPR1A Antibody||BMPR1A Protein||BMPR1A cDNA||BMPR1A ELISA Kit|
|BMPR1B||BMPR1B Antibody||BMPR1B Protein||BMPR1B cDNA||BMPR1B ELISA Kit|
|BMPR2||BMPR2 Antibody||BMPR2 Protein||BMPR2 cDNA||BMPR2 ELISA Kit|
|CTNNB1||CTNNB1 Antibody||CTNNB1 Protein||CTNNB1 cDNA||CTNNB1 ELISA Kit|
|DLX5||DLX5 Antibody||DLX5 Protein||DLX5 cDNA||DLX5 ELISA Kit|
|DUSP9||DUSP9 Antibody||DUSP9 Protein||DUSP9 cDNA||DUSP9 ELISA Kit|
|DVL1||DVL1 Antibody||DVL1 Protein||DVL1 cDNA||DVL1 ELISA Kit|